N,N-dimethyltryptamine (DMT) is a potent psychedelic naturally produced by many plants and animals, including humans. Whether or not DMT is significant to mammalian physiology, especially within the central nervous system, is a debate that started in the early 1960s and continues to this day. This review integrates historical and recent literature to clarify this issue, giving special attention to the most controversial subjects of DMT’s biosynthesis, its storage in synaptic vesicles and the activation receptors like sigma-1. Less discussed topics, like DMT’s metabolic regulation or the biased activation of serotonin receptors, are highlighted. We conclude that most of the arguments dismissing endogenous DMT’s relevance are based on obsolete data or misleading assumptions. Data strongly suggest that DMT can be relevant as a neurotransmitter, neuromodulator, hormone and immunomodulator, as well as being important to pregnancy and development. Key experiments are addressed to definitely prove what specific roles DMT plays in mammalian physiology.
Abou JamraRSircarIBeckerT, et al. (2005) A family-based and case-control association study of trace amine receptor genes on chromosome 6q23 in bipolar affective disorder. Mol Psychiatry10: 618–620.
AlonsoJFRomeroSMañanasMÀ, et al. (2015) Serotonergic psychedelics temporarily modify information transfer in humans. Int J Neuropsychopharmacol18: pyv039.
6.
AranedaRAndradeR (1991) 5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience40: 399–412.
AxelrodJ (1961) Enzymatic formation of psychotomimetic metabolites from normally occurring compounds. Science134: 343.
9.
AxelrodJ (1962) The enzymatic N-methylation of serotonin and other amines. J Pharmacol Exp Ther138: 28–33.
10.
BardJAZgombickJAdhamN, et al. (1993) Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J Biol Chem268: 23422–23426.
11.
BarkerSA (2018) N, N-Dimethyltryptamine (DMT), an endogenous hallucinogen: Past, present, and future research to determine its role and function. Front Neurosci12: 536.
12.
BarkerSABeatonJMChristianST, et al. (1982) Comparison of the brain levels of N,N-dimethyltryptamine and alpha, alpha, beta, beta-tetradeutero-N-N-dimethyltryptamine following intraperitoneal injection. The in vivo kinetic isotope effect. Biochem Pharmacol31: 2513–2516.
13.
BarkerSABeatonJMChristianST, et al. (1984) In vivo metabolism of alpha,alpha,beta,beta-tetradeutero-N, N-dimethyltryptamine in rodent brain. Biochem Pharmacol33: 1395–1400.
14.
BarkerSABorjiginJLomnickaI, et al. (2013) LC/MS/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate. Biomed Chromatogr27: 1690–1700.
15.
BarkerSAMcIlhennyEHStrassmanR (2012) A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010. Drug Test Anal4: 617–635.
16.
BarkerSAMontiJAChristianST (1980) Metabolism of the hallucinogen N,N-dimethyltryptamine in rat brain homogenates. Biochem Pharmacol29: 1049–1057.
17.
BarkerS. A.MontiJ. A.ChristianS. T. (1981). N, N-dimethyltryptamine: An endogenous hallucinogen. International Review of Neurobiology, 22, 83–110. https://doi.org/10.1016/s0074-7742(08)60291-3
18.
BeatonJMMorrisPE (1984) Ontogeny of N,N-dimethyltryptamine and related indolealkylamine levels in neonatal rats. Mech Ageing Dev25: 343–347.
19.
BeliveauVGanzMFengL, et al. (2017) A high-resolution in vivo atlas of the human brain’s serotonin system. J Neurosci37: 120–128.
20.
BergKAMaayaniSGoldfarbJ, et al. (1998) Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus. Mol Pharmacol54: 94–104.
21.
BerryMD (2004) Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J Neurochem90: 257–271.
22.
BerryMDShitutMRAlmousaA, et al. (2013) Membrane permeability of trace amines: Evidence for a regulated, activity-dependent, nonexocytotic, synaptic release. Synapse67: 656–667.
23.
BhattacharyyaSPuriSMilediR, et al. (2002) Internalization and recycling of 5-HT2A receptors activated by serotonin and protein kinase C-mediated mechanisms. Proc Natl Acad Sci USA99: 14470–14475.
24.
BhikharidasBMannLRMcLeodWR (1975) Indolamine N-methyltransferase activity in human tissues. J Neurochem24: 203–205.
25.
BloughBELandavazoADeckerAM, et al. (2014) Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes. Psychopharmacology231: 4135–4144.
26.
BorjiginJLiuT (2008) Application of long-term microdialysis in circadian rhythm research. Pharmacol Biochem Behav90: 148–155.
27.
BorowskyBAdhamNJonesKA, et al. (2001) Trace amines: Identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA98: 8966–8971.
28.
BousquetPHudsonAGarcía-SevillaJA, et al. (2020) Imidazoline receptor system: The past, the present, and the future. Pharmacol Rev72: 50–79.
29.
BoysonSJAlexanderA (1990) Net production of cerebrospinal fluid is decreased by SCH-23390. Ann Neurol27: 631–635.
30.
BradleyPBBriggsI (1974) Further studies on the mode of action of psychotomimetic drugs: Antagonism of the excitatory actions of 5-hydroxytryptamine by methylated derivatives of tryptamine. Br J Pharmacol50: 345–354.
31.
BrailoiuEChakrabortySBrailoiuGC, et al. (2019) Choline is an intracellular messenger linking extracellular stimuli to IP3-Evoked Ca2+ signals through sigma-1 receptors. Cell Rep26: 330–337.e4.
32.
BrogdenRNSorkinEM (1990) Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease. Drugs40: 903–949.
33.
BrunsDRiedelDKlingaufJ, et al. (2000) Quantal release of serotonin. Neuron28: 205–220.
34.
BunzowJRSondersMSArttamangkulS, et al. (2001) Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol60: 1181–1188.
35.
BurianKGestringGF (1971) Discrepancies between subjective and objective acoustic thresholds. Arch Klin Exp Ohren Nasen Kehlkopfheilkd198: 73–84.
36.
CallawayJC (1988) A proposed mechanism for the visions of dream sleep. Med Hypotheses26: 119–124.
37.
CarbonaroTMEshlemanAJForsterMJ, et al. (2015) The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice. Psychopharmacology232: 275–284.
38.
CarbonaroTMGatchMB (2016) Neuropharmacology of N,N-dimethyltryptamine. Brain Res Bull126(Pt 1): 74–88.
39.
ChristensonJGDairmanWUdenfriendS (1970) Preparation and properties of a homogeneous aromatic L-amino acid decarboxylase from hog kidney. Arch Biochem Biophys141: 356–367.
40.
ChristianSTBeningtonFMorinRD, et al. (1975) Gas-liquid chromatographic separation and identification of biologically important indolealkylamines from human cerebrospinal fluid. Biochem Med14: 191–200.
41.
ChristianSTHarrisonRPagelJ (1976) Evidence for dimethyltryptamine (DMT) as a naturally-occurring transmitter in mammalian brain. Ala J Med Sci13: 162–165.
42.
ChristianSTHarrisonRQuayleE, et al. (1977) The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent. Biochem Med18: 164–183.
43.
ChuUMavlyutovTSchulmanA, et al. (2015) Methylation of thiols and thioethers by human indolethylamine-N methyltransferase. FASEB J29: 1022–1027.
44.
ChuUBVorperianSKSatyshurK, et al. (2014) Noncompetitive inhibition of indolethylamine-N-methyltransferase by N,N-dimethyltryptamine and N,N-dimethylaminopropyltryptamine. Biochemistry53: 2956–2965.
45.
CichonSWingeIMattheisenM, et al. (2008) Brain-specific tryptophan hydroxylase 2 (TPH2): A functional Pro206Ser substitution and variation in the 5′-region are associated with bipolar affective disorder. Hum Mol Genet17: 87–97.
46.
ColeJMPieperWA (1973) The effects of N,N-dimethyltryptamine on operant behavior in squirrel monkeys. Psychopharmacologia29: 107–112.
47.
ComaiSBertazzoACarrettiN, et al. (2010) Serum levels of tryptophan, 5-hydroxytryptophan and serotonin in patients affected with different forms of amenorrhea. Int J Tryptophan Res3: 69–75.
48.
CorbettLChristianSTMontiJA, et al. (1975) Interaction of psychoactive drugs with the Mg+2 requiring ATPase associated with isolated synaptic vesicles. Res Commun Chem Pathol Pharmacol11: 605–613.
49.
CozziNVGopalakrishnanAAndersonLL, et al. (2009) Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter. J Neural Transm (Vienna)116: 1591–1599.
50.
CozziNVMavlyutovTAThompsonMA, et al. (2011) Indolethylamine N-methyltransferase expression in primate nervous tissue. Soc Neurosci37: 840.19.
51.
DeanJG (2018) Indolethylamine-N-methyltransferase polymorphisms: Genetic and biochemical approaches for study of endogenous N,N,-dimethyltryptamine. Front Neurosci12: 232.
52.
DeanJGLiuTHuffS, et al. (2019) Biosynthesis and extracellular concentrations of N,N-dimethyltryptamine (DMT) in mammalian brain. Sci Rep9: 9333.
53.
DeFranceJFMcCreaRAYoshiharaH (1975) Effects of certain indoleamines in the hippocampal-septal circuit. Exp Neurol48: 352–377.
54.
DuanJMartinezMSandersAR, et al. (2004) Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia. Am J Hum Genet75: 624–638.
55.
DyckLE (1989) Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor. Life Sci44: 1149–1156.
56.
ErricoMCrozierRAPlummerMR, et al. (2001) 5-HT(7) receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons. Neuroscience102: 361–367.
57.
EshlemanAJForsterMJWolfrumKM, et al. (2014) Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: Mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function. Psychopharmacology231: 875–888.
58.
FerreroDMWackerDRoqueMA, et al. (2012) Agonists for 13 trace amine-associated receptors provide insight into the molecular basis of odor selectivity. ACS Chem Biol7: 1184–1189.
59.
FontanillaDJohannessenMHajipourAR, et al. (2009) The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science323: 934–937.
60.
FrecskaESzaboAWinkelmanMJ, et al. (2013) A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity. J Neural Transm (Vienna)120: 1295–1303.
61.
GainetdinovRRHoenerMCBerryMD (2018) Trace amines and their receptors. Pharmacol Rev70: 549–620.
62.
GillinJCCannonEMagyarR, et al. (1973) Failure of N,N-dimethyltryptamine to evoke tolerance in cats. Biol Psychiatry7: 213–220.
63.
GillinJCKaplanJStillmanR, et al. (1976) The psychedelic model of schizophrenia: The case of N,N-dimethyltryptamine. Am J Psychiatry133: 203–208.
64.
GomesMMCoimbraJBClaraRO, et al. (2014) Biosynthesis of N,N-dimethyltryptamine (DMT) in a melanoma cell line and its metabolization by peroxidases. Biochem Pharmacol88: 393–401.
65.
González-MaesoJWeisstaubNVZhouM, et al. (2007) Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron53: 439–452.
66.
González-MaesoJYuenTEbersoleBJ, et al. (2003) Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. J Neurosci23: 8836–8843.
67.
GrammenosDBarkerSA (2015) On the transmethylation hypothesis: Stress, N,N-dimethyltryptamine, and positive symptoms of psychosis. J Neural Transm (Vienna)122: 733–739.
68.
HayashiTSuTP (2004) Sigma-1 receptor ligands: Potential in the treatment of neuropsychiatric disorders. CNS Drugs18: 269–284.
69.
HeissWDHoyerJPoustkaF (1973) Participation of retinal mechanisms in DMT hallucinations. Experientia29: 455–457.
70.
HermanKSBowsherRRHenryDP (1985) Synthesis of N pi-methylhistamine and N alpha-methylhistamine by purified rabbit lung indolethylamine N-methyltransferase. J Biol Chem260: 12336–12340.
71.
IkemotoKKitahamaKJouvetA, et al. (1997) Demonstration of L-dopa decarboxylating neurons specific to human striatum. Neurosci Lett232: 111–114.
72.
IkemotoKKitahamaKNishimuraA, et al. (1999) Tyrosine hydroxylase and aromatic L-amino acid decarboxylase do not coexist in neurons in the human anterior cingulate cortex. Neurosci Lett269: 37–40.
73.
IllesS (2017) More than a drainage fluid: The role of CSF in signaling in the brain and other effects on brain tissue. Handb Clin Neurol146: 33–46.
74.
JacobMSPrestiDE (2005) Endogenous psychoactive tryptamines reconsidered: An anxiolytic role for dimethyltryptamine. Med Hypotheses64: 930–937.
75.
JaegerCB (1986) Aromatic L-amino acid decarboxylase in the rat brain: Immunocytochemical localization during prenatal development. Neuroscience18: 121–150.
76.
JaegerCBRuggieroDAAlbertVR, et al. (1984) Aromatic L-amino acid decarboxylase in the rat brain: Immunocytochemical localization in neurons of the brain stem. Neuroscience11: 691–713.
77.
JaegerCBTeitelmanGJohTH, et al. (1983) Some neurons of the rat central nervous system contain aromatic-L-amino-acid decarboxylase but not monoamines. Science219: 1233–1235.
78.
JenkinsB (2020) Migraine management. Aust Prescr43: 148–151.
79.
JohannessenMFontanillaDMavlyutovT, et al. (2011) Antagonist action of progesterone at σ-receptors in the modulation of voltage-gated sodium channels. Am J Physiol Cell Physiol300: C328–C337.
80.
JohansenPAJenningsICottonRG, et al. (1996) Phosphorylation and activation of tryptophan hydroxylase by exogenous protein kinase A. J Neurochem66: 817–823.
81.
JuorioAVDurdenDA (1984) The distribution and turnover of tryptamine in the brain and spinal cord. Neurochem Res9: 1283–1293.
82.
JuorioAVGreenshawAJWishartTB (1988) Reciprocal changes in striatal dopamine and beta-phenylethylamine induced by reserpine in the presence of monoamine oxidase inhibitors. Naunyn Schmiedebergs Arch Pharmacol338: 644–648.
83.
KasperDLFauciASHauserSL, et al. (2015) Harrison’s Principles of Internal Medicine, 19th edn. New York, NY: McGraw Hill Education.
84.
KeiserMJSetolaVIrwinJJ, et al. (2009) Predicting new molecular targets for known drugs. Nature462: 175–181.
85.
KenakinT (1995) Agonist-receptor efficacy. II. Agonist trafficking of receptor signals. Trends Pharmacol Sci16: 232–238.
86.
KomoriKFujiiTKarasawaN, et al. (1991) Some neurons of the mouse cortex and caudo-putamen contain aromatic L-amino acid decarboxylase but monoamines. Acta Histochem Cytochem24: 571–577.
87.
Kurrasch-OrbaughDMParrishJCWattsVJ, et al. (2003a) A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: The involvement of MAP kinases. J Neurochem86: 980–991.
88.
Kurrasch-OrbaughDMWattsVJBarkerEL, et al. (2003b) Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves. J Pharmacol Exp Ther304: 229–237.
89.
KvachninaELiuGDityatevA, et al. (2005) 5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. J Neurosci25: 7821–7830.
90.
LambeEKAghajanianGK (2006) Hallucinogen-induced UP states in the brain slice of rat prefrontal cortex: Role of glutamate spillover and NR2B-NMDA receptors. Neuropsychopharmacology31: 1682–1689.
91.
LinRLNarasimhachariNHimwichHE (1973) Inhibition of indolethylamine-N-methyltransferase by S-adenosylhomocysteine. Biochem Biophys Res Commun54: 751–759.
92.
LinRLSargeantSNarasimhachariN (1974) Indolethylamine-N-methyltransferase in developing rabbit lung. Dev Psychobiol7: 475–481.
93.
Lindvall-AxelssonM.MathewC.NilssonC.OwmanC. (1988). Effect of 5-hydroxytryptamine on the rate of cerebrospinal fluid production in rabbit. Experimental Neurology, 99(2), 362–368. https://doi.org/10.1016/0014-4886(88)90154-9
94.
Lindvall-AxelssonMMathewCNilssonC, et al. (1981) Autonomic nerves in the mammalian choroid plexus and their influence on the formation of cerebrospinal fluid. J Cereb Blood Flow Metab1: 245–266.
95.
López-GiménezJFGonzález-MaesoJ (2018) Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways. Curr Top Behav Neurosci36: 45–73.
LyCGrebACCameronLP, et al. (2018) Psychedelics promote structural and functional neural plasticity. Cell Rep23: 3170–3182.
98.
McEwenCMSoberAJ (1967) Rabbit serum monoamine oxidase. II. Determinants of substrate specificity. J Biol Chem242: 3068–3078.
99.
MandelLRAhnHSVandenHeuvelWJ (1972) Indoleamine-N-methyl transferase in human lung. Biochem Pharmacol21: 1197–1200.
100.
MandelLRRokachJRooneyCS, et al. (1978) Inhibition of dimethyltryptamine biosynthesis by N,N’-bis-(3-methyl-2-thiazolidinylidene)succinamide (I) and 2-imino-3-methylthiazolidine (II). Mol Pharmacol14: 930–939.
101.
MandellAJMorganM (1971) Indole(ethyl)amine N-methyltransferase in human brain. Nature230: 85–87.
102.
MavlyutovTAEpsteinMLLiuP, et al. (2012) Development of the sigma-1 receptor in C-terminals of motoneurons and colocalization with the N,N’-dimethyltryptamine forming enzyme, indole-N-methyl transferase. Neuroscience206: 60–68.
103.
MellerEFriedmanESchweitzerJW, et al. (1977) Tetrahydro-beta-carbolines: Specific inhibitors of type A monoamine oxidase in rat brain. J Neurochem28: 995–1000.
104.
MengodGVilaróMTCortésR, et al. (2006) Chemical neuroanatomy of 5-HT receptor subtypes in the mammalian brain. In: BLRoth (ed.) The Serotonin Receptors - From Molecular Pharmacology to Human Theraputics. Totowa, NJ: Humana Press, pp.319–364.
105.
MonnetFPMauriceT (2006) The sigma1 protein as a target for the non-genomic effects of neuro(active)steroids: Molecular, physiological, and behavioral aspects. J Pharmacol Sci100: 93–118.
106.
Morales-GarciaJACalleja-CondeJLopez-MorenoJA, et al. (2020) N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo. Transl Psychiatry10: 331.
107.
MorganMMandellAJ (1969) Indole(ethyl)amine N-methyltransferase in the brain. Science165: 492–493.
108.
MuschampJWReginaMJHullEM, et al. (2004) Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex. Brain Res1023: 134–140.
109.
NardaiSLászlóMSzabóA, et al. (2020) N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats. Exp Neurol327: 113245.
110.
NemesBPetőKNémethN, et al. (2019) N,N-dimethyltryptamine prevents renal ischemia-reperfusion injury in a rat model. Transplant Proc51: 1268–1275.
111.
NicholsCDNicholsDE (2020) DMT in the mammalian brain: A critical appraisal. ALIUS Bull4: 16–22.
112.
NicholsCDSanders-BushE (2002) A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain. Neuropsychopharmacology26: 634–642.
NicholsDE (2018) N,N-dimethyltryptamine and the pineal gland: Separating fact from myth. J Psychopharmacol32: 30–36.
116.
NickersonM (1956) Receptor occupancy and tissue response. Nature178: 697–698.
117.
NocjarCAlexKDSonnebornA, et al. (2015) Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex. Neuroscience297: 22–37.
118.
Nuño-AyalaMGuillénNArnalC, et al. (2012) Cystathionine β-synthase deficiency causes infertility by impairing decidualization and gene expression networks in uterus implantation sites. Physiol Genomics44: 702–716.
119.
O’MalleyKLHarmonSMoffatM, et al. (1995) The human aromatic L-amino acid decarboxylase gene can be alternatively spliced to generate unique protein isoforms. J Neurochem65: 2409–2416.
120.
OonMCMurrayRMRodnightR, et al. (1977) Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects. Psychopharmacology54: 171–175.
121.
OsmondHSmythiesJ (1952) Schizophrenia: A new approach. J Ment Sci98: 309–315.
122.
PaeCUDragoAKimJJ, et al. (2010) TAAR6 variations possibly associated with antidepressant response and suicidal behavior. Psychiatry Res180: 20–24.
123.
PaeCUDragoAPatkarAA, et al. (2009) Epistasis between a set of variations located in the TAAR6 and HSP-70 genes toward schizophrenia and response to antipsychotic treatment. Eur Neuropsychopharmacol19: 806–811.
124.
PaeCUYuHSAmannD, et al. (2008) Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample. J Psychiatr Res42: 35–40.
125.
PazosAPalaciosJM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res346: 205–230.
126.
PetoKNemethNMesterA, et al. (2018) Hemorheological and metabolic consequences of renal ischemia-reperfusion and their modulation by N,N-dimethyl-tryptamine on a rat model. Clin Hemorheol Microcirc70: 107–117.
127.
PiechotaMKorostynskiMSikoraM, et al. (2012) Common transcriptional effects in the mouse striatum following chronic treatment with heroin and methamphetamine. Genes Brain Behav11: 404–414.
128.
PortaREspositoCCamardellaM, et al. (1979) Multiple forms of rabbit lung indoleamine-N-methyltransferase. Int J Biochem10: 919–923.
129.
PurvesDAugustineGJFitzpatrickD, et al. (2001) (eds) What defines a neurotransmitter? In: Neuroscience, 2nd edn. Sunderland, MA: Sinauer Associates. Available at: https://www.ncbi.nlm.nih.gov/books/NBK10957/ (accessed 13 February 2022).
130.
RäisänenMKärkkäinenJ (1978) Quantitative assay of the N-methylated metabolites of tryptamine and serotonin by gas chromatography mass spectrometry as applied to the determination of lung indoleethylamine N-methyltransferase activity. Biomed Mass Spectrom5: 596–600.
131.
RayTS (2010) Psychedelics and the human receptorome. PLoS One5: e9019.
132.
RibaJAndererPJanéF, et al. (2004) Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: A functional neuroimaging study using low-resolution electromagnetic tomography. Neuropsychobiology50: 89–101.
133.
RibaJMcIlhennyEHBousoJC, et al. (2015) Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: A comparative study. Drug Test Anal7: 401–406.
134.
RibaJMcIlhennyEHValleM, et al. (2012) Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca. Drug Test Anal4: 610–616.
135.
RibaJRodríguez-FornellsAUrbanoG, et al. (2001) Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers. Psychopharmacology154: 85–95.
136.
RibaJValleMUrbanoG, et al. (2003) Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. J Pharmacol Exp Ther306: 73–83.
137.
RickliAMoningODHoenerMC, et al. (2016) Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. Eur Neuropsychopharmacol26: 1327–1337.
138.
RothmanRBAyestasMADerschCM, et al. (1999) Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension. Circulation100: 869–875.
139.
RothmanRBBeckettsKMRadescaLR, et al. (1993) Studies of the biogenic amine transporters. II. A brief study on the use of [3H]DA-uptake-inhibition to transporter-binding-inhibition ratios for the in vitro evaluation of putative cocaine antagonists. Life Sci53: PL267–PL272.
140.
RutiglianoGZucchiR (2020) Molecular variants in human trace amine-associated receptors and their implications in mental and metabolic disorders. Cell Mol Neurobiol40: 239–255.
141.
RyskampDAKorbanSZhemkovV, et al. (2019) Neuronal sigma-1 receptors: Signaling functions and protective roles in neurodegenerative diseases. Front Neurosci13: 862.
142.
SaavedraJMAxelrodJ (1972) Psychotomimetic N-methylated tryptamines: Formation in brain in vivo and in vitro. Science175: 1365–1366.
143.
SaavedraJMCoyleJTAxelrodJ (1973) The distribution and properties of the nonspecific N-methyltransferase in brain. J Neurochem20: 743–752.
144.
SangiahSGomezMVDominoEF (1979) Accumulation of N,N-dimethyltryptamine in rat brain cortical slices. Biol Psychiatry14: 925–936.
145.
SchmidCLRaehalKMBohnLM (2008) Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo. Proc Natl Acad Sci USA105: 1079–1084.
146.
ScruggsJLSchmidtDDeutchAY (2003) The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats. Neurosci Lett346: 137–140.
147.
ShulginAShulginA (1997) TiHKAL: The Continuation. Berkeley, CA: Transform Press.
148.
SimmlerLDBuchyDChabozS, et al. (2016) In vitro characterization of psychoactive substances at rat, mouse, and human trace amine-associated receptor 1. J Pharmacol Exp Ther357: 134–144.
149.
SitaramBRLockettLTalomsinR, et al. (1987) In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat. Biochem Pharmacol36: 1509–1512.
150.
SmithRLCantonHBarrettRJ, et al. (1998) Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors. Pharmacol Biochem Behav61: 323–330.
151.
SperanzaLGiulianoTVolpicelliF, et al. (2015) Activation of 5-HT7 receptor stimulates neurite elongation through mTOR, Cdc42 and actin filaments dynamics. Front Behav Neurosci9: 62.
152.
SperanzaLLabusJVolpicelliF, et al. (2017) Serotonin 5-HT7 receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons. J Neurochem141: 647–661.
153.
StrahilevitzMOthmerENarasimhachariN, et al. (1977) Plasma indolethylamine-n-methyltransferase activity and growth hormone level during sleep: A pilot study. Biol Psychiatry12: 171–180.
154.
StrassmanRJ (1996) Human psychopharmacology of N,N-dimethyltryptamine. Behav Brain Res73: 121–124.
155.
StrassmanRJ (2001) DMT: The Spirit Molecule: A Doctor’s Revolutionary Research Into the Biology of Near-Death and Mystical Experiences. Rochester: Park Street Press.
156.
StrassmanR. J.QuallsC. R. (1994). Dose-response study of N, N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects. Archives of General Psychiatry, 51(2), 85–97. https://doi.org/10.1001/archpsyc.1994.03950020009001
157.
StrassmanRJQuallsCRBergLM (1996) Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans. Biol Psychiatry39: 784–795.
158.
SuzukiOKatsumataYOyaM (1981) Characterization of eight biogenic indoleamines as substrates for type A and type B monoamine oxidase. Biochem Pharmacol30: 1353–1358.
159.
SzaboA. (2015). Psychedelics and immunomodulation: Novel approaches and therapeutic opportunities. Frontiers in Immunology, 6, 358. https://doi.org/10.3389/fimmu.2015.00358
160.
SzaboAKovacsARibaJ, et al. (2016) The endogenous hallucinogen and trace amine N,N-dimethyltryptamine (DMT) displays potent protective effects against hypoxia via sigma-1 receptor activation in human primary iPSC-derived cortical neurons and microglia-like immune cells. Front Neurosci10: 423.
161.
SzáraS (1956) Dimethyltryptamin: Its metabolism in man; the relation to its psychotic effect to the serotonin metabolism. Experientia12: 441–442.
162.
TakahashiTTakahashiKIdoT, et al. (1985) 11C-labeling of indolealkylamine alkaloids and the comparative study of their tissue distributions. Int J Appl Radiat Isot36: 965–969.
163.
ThompsonMAMoonEKimUJ, et al. (1999) Human indolethylamine N-methyltransferase: cDNA cloning and expression, gene cloning, and chromosomal localization. Genomics61: 285–297.
164.
ThompsonMAWeinshilboumRM (1998) Rabbit lung indolethylamine N-methyltransferase. cDNA and gene cloning and characterization. J Biol Chem273: 34502–34510.
165.
TimmermannCRosemanLSchartnerM, et al. (2019) Neural correlates of the DMT experience assessed with multivariate EEG. Sci Rep9: 16324.
166.
TimmermannCRosemanLWilliamsL, et al. (2018) DMT models the near-death experience. Front Psychol9: 1424.
167.
TourinoMCde OliveiraEMBelléLP, et al. (2013) Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells. Cell Biochem Funct31: 361–364.
168.
ValleMMaquedaAERabellaM, et al. (2016) Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans. Eur Neuropsychopharmacol26: 1161–1175.
169.
WaldmeierPCMaîtreL (1977) Neurochemical investigations of the interaction of N,N-dimethyltryptamine with dopaminergic system in rat brain. Psychopharmacology52: 137–144.
170.
WuHDongAZengH, et al. (2005) The crystal structure of human indolethylamine N-methyltransferase in complex with SAH. Protein Data Bank Entry 2A14.
171.
WyattRJSaavedraJMAxelrodJ (1973) A dimethyltryptamine-forming enzyme in human blood. Am J Psychiatry130: 754–760.
172.
YanaiKIdoTIshiwataK, et al. (1986) In vivo kinetics and displacement study of a carbon-11-labeled hallucinogen, N,N-[11C]dimethyltryptamine. Eur J Nucl Med12: 141–146.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
